Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. Graeme L Fraser et al

18/08/2021,

Serge Rozenberg

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372662/

Next meeting

28/03/2026

BMS meeting : Management of complex cases Saturday 28.03.26

Latest news

16/01/2026

Guidelines Menopause BMS